SFX by Ex Libris Inc.

Title:	Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
Source:	Science [0036-8075] Dudley, M E yr:2002

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dudley, Mark E E. "Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma." Journal of clinical oncology 23.10 (2005): 2346-57.
description	2.	Morgan, Richard A. "Cancer regression in patients after transfer of genetically engineered lymphocytes." Science 314.5796 (2006): 126-9.
description	3.	Meidenbauer, N. "Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients." The journal of immunology 170.4 (2003): 2161-9.
description	4.	Dudley, M. "Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma." Journal of immunotherapy 24.4 (1997): 363-373.
description	5.	Dudley, Mark E E. "Adoptive-cell-transfer therapy for the treatment of patients with cancer." Nature reviews. Cancer 3.9 (2003): 666-75.
description	6.	Robbins, Paul F. "Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1." Journal of clinical oncology 29.7 (2011): 917-24.
description	7.	Morgan, Richard A. "Cancer regression in patients after transfer of genetically engineered lymphocytes.(REPORTS)." Science 314.5796 (2006): 126-.
description	8.	Johnson, Laura A. A. "Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes." The journal of immunology 177.9 (2006): 6548-59.
description	9.	Whiteside, Theresa L L. "Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention." Seminars in cancer biology 16.1 (2006): 3-15.
description	10.	Offringa R, R. "Cancer. Cancer immunotherapy is more than a numbers game." Science 314.5796: 68-9.
description	11.	Greenberg, P D D. "Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells." Proceedings of the National Academy of Sciences of the United States of America 99.25 (2003): 16168-73.
description	12.	Rosenberg, S A A. "Progress in human tumour immunology and immunotherapy." Nature 411.6835 (2001): 380-4.
description	13.	Rosenberg, Steven A A. "A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma." Journal of immunotherapy (2002): 243-51.
description	14.	Frazer, Ian H H. "Prevention of cervical cancer through papillomavirus vaccination." Nature reviews. Immunology 4.1 (2003): 46-54.
description	15.	Kershaw, Michael H H. "A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer." Clinical cancer research 12.20 (2006): 6106-15.
description	16.	Hodi, Steven S. "Improved Survival with Ipilimumab in Patients with Metastatic Melanoma." New England Journal of Medicine, The 363.8 (2010): 711-723.
description	17.	Okamura, H. "Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu." Cytokine & growth factor reviews 12.1: 53-72.
description	18.	Robbins, Paul F F. "Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy." The journal of immunology 173.12 (2005): 7125-30.
description	19.	ROSENBERG, S. "TREATMENT OF PATIENTS WITH METASTATIC MELANOMA WITH AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2." Journal of the National Cancer Institute 86.15 (1994): 1159-1166.
description	20.	Stanislawski, T. "Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer." Nature immunology 2.10 (2001): 962-70.